Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetic cardiomyopathy

F S Fein1, E H Sonnenblick

  • 1Albert Einstein College of Medicine, Bronx, NY 10461.

Cardiovascular Drugs and Therapy
|February 1, 1994
PubMed
Summary
This summary is machine-generated.

Diabetic cardiomyopathy is a heart condition in diabetics, increasing congestive heart failure risk. Studies reveal cardiac structural and functional changes, influenced by factors like hypertension.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

MYOCARDIAL FINE STRUCTURE AND FUNCTION.

A listing of research in the cardiovascular field·2014
Same author

Congestive heart failure. Biochemical and physiological considerations. Combined clinical staff conference at the National Institutes of Health.

Annals of internal medicine·2013
Same author

Coronary flow reserve of nonischemic heart failure.

Congestive heart failure (Greenwich, Conn.)·2002
Same author

Persistent formation of angiotensin II despite treatment with maximally recommended doses of angiotensin converting enzyme inhibitors in patients with chronic heart failure.

Journal of the renin-angiotensin-aldosterone system : JRAAS·2002
Same author

Cardiomyocyte aging is gender-dependent: the local IGF-1-IGF-1R system.

Heart disease (Hagerstown, Md.)·2001
Same author

Perindopril treatment for congestive heart failure.

The American journal of cardiology·2001

Area of Science:

  • Cardiology
  • Diabetology
  • Pathophysiology

Background:

  • Diabetic cardiomyopathy is a distinct cardiac condition in diabetes mellitus.
  • Diabetes significantly increases the risk of congestive heart failure (CHF).
  • Hypertension is a key cofactor in fatal CHF among diabetics.

Purpose of the Study:

  • To review the pathophysiology and clinical presentation of diabetic cardiomyopathy.
  • To explore the impact of diabetes on cardiac structure and function.
  • To discuss findings from human and experimental studies.

Main Methods:

  • Review of epidemiological data (Framingham study).
  • Analysis of pathological and cardiac catheterization findings.
  • Examination of noninvasive cardiac studies and experimental models (diabetic dogs and rats).

Related Experiment Videos

Main Results:

  • Diabetics show increased CHF incidence, left ventricular hypertrophy, fibrosis, and small vessel disease.
  • Symptomatic patients exhibit congestive or restrictive patterns; asymptomatic patients have decreased left ventricular compliance.
  • Experimental models show altered myocardial mechanics, myosin ATPase activity, Ca2+ fluxes, and adrenergic responses.

Conclusions:

  • Diabetic cardiomyopathy presents with altered cardiac structure and function, particularly diastolic dysfunction.
  • Microvascular complications and hypertension exacerbate cardiac issues in diabetics.
  • Biochemical changes in the diabetic heart may stem from metabolic alterations.